Nuclear Medicine Equipment Market Report 2026

Nuclear Medicine Equipment Market Overview

• Nuclear Medicine Equipment market size has reached to $2.81 billion in 2025 • Expected to grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% • Growth Driver: Rising Cardiac Ailments Fuel Growth In Nuclear Medicine Equipment Market • Market Trend: Technological Advancements In Nuclear Medicine • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nuclear Medicine Equipment Market?

Nuclear medicine equipment refers to specialized medical devices used in nuclear medicine to diagnose and treat diseases using radioactive substances. These devices capture images of organs and tissues or deliver targeted radiation therapy. Nuclear medicine equipment allows for early diagnosis, treatment planning, and monitoring of various diseases, particularly cancers and cardiovascular disorders. The main products of nuclear medicine equipment are single photon emission computed tomography, hybrid positron emission tomography, and planar scintigraphy. Single photon emission computed tomography is an imaging technique that uses gamma rays to create detailed, three-dimensional images of the inside of the body. It is applied for oncology, cardiology, neurology, and others by various end users such as hospitals, imaging centers, academic and research institutes, and others.

What Is The Nuclear Medicine Equipment Market Growth Forecast?

The nuclear medicine equipment market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growth in theranostics adoption, increasing precision medicine demand, technological advancements in hybrid imaging, rising cardiovascular disease burden, expansion of imaging centers in emerging markets. Major trends in the forecast period include advanced hybrid imaging systems, expansion of theranostics applications, increasing adoption of personalized nuclear diagnostics, growing focus on radiation dose optimization, rising demand for outpatient nuclear imaging services.

Global Nuclear Medicine Equipment Market Segmentation

1) By Product: Single Photon Emission Computed Tomography, Hybrid Positron Emission Tomography, Planar Scintigraphy 2) By Application: Oncology, Cardiology, Neurology, Other Applications 3) By End User: Hospitals, Imaging Centers, Academic And Research Institutes, Other End Users Subsegments: 1) By Single Photon Emission Computed Tomography: Standalone SPECT Systems, Hybrid SPECT Or CT Systems 2) By Hybrid Positron Emission Tomography: PET Or CT Systems, PET Or MRI Systems 3) By Planar Scintigraphy: Cardiac Imaging Systems, Bone Scintigraphy Systems, Thyroid Imaging Systems

What Is The Driver Of The Nuclear Medicine Equipment Market?

The increasing prevalence of cardiac ailments is expected to propel the growth of the nuclear medicine equipment market going forward. Cardiac ailments, also known as heart or cardiovascular diseases, refer to a broad range of conditions affecting the heart and blood vessels. These ailments can impact heart function, structure, or the blood flow to and from the heart. The prevalence of cardiac ailments is primarily attributed to factors such as aging populations, lifestyle choices (such as poor diet and lack of exercise), environmental exposures, and advancements in diagnostic technologies leading to better detection. Nuclear medicine equipment is used in the management of cardiac ailments to provide precise imaging and diagnostic information that helps in early detection, accurate staging, and effective monitoring of these diseases. For instance, in January 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the increasing prevalence of cardiac ailments drives the growth of the nuclear medicine equipment industry.

Key Players In The Global Nuclear Medicine Equipment Market

Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.

Global Nuclear Medicine Equipment Market Trends and Insights

Major companies operating in the nuclear medicine equipment market are focused on developing advanced products, such as PET/T scanners, to provide highly detailed, functional images of the body's metabolic processes. A PET/CT scanner is an advanced imaging device used in nuclear medicine that combines two technologies, positron emission tomography (PET) and computed tomography (CT). This dual-modality scanner provides functional and anatomical imaging in a single session, allowing doctors to detect and diagnose various conditions more accurately. For instance, in June 2024, Siemens Healthineers, a Germany-based healthcare company, launched the Biograph Trinion PET/CT scanner. The PET scanner boasts a unique, scalable axial field-of-view design, allowing on-site technological upgrades without needing costly room renovations or disrupting workflow. It features a lutetium oxyorthosilicate (LSO) crystal detector that offers high spatial resolution and an ultrafast time-of-flight performance of 239 picoseconds, enhancing small lesion detectability and providing adequate sensitivity up to 128 cps/kBq. This results in rapid scans with reduced patient radiation doses. Additionally, the Biograph Trinion includes a new air-cooled digital detector, simplifying installation compared to traditional water-cooled systems.

What Are Latest Mergers And Acquisitions In The Nuclear Medicine Equipment Market?

In November 2023, Mirion Technologies Inc, a US-based company specializing in radiation detection, measurement, and protection equipment, acquired ec2 Software Solutions for an undisclosed amount. With this acquisition, Mirion Technologies aims to strengthen its nuclear medicine and molecular imaging portfolio by integrating ec2’s advanced software solutions and enhancing its capabilities in providing comprehensive and innovative imaging and data management solutions. ec² Software Solutions is a US-based provider of nuclear medicine equipment.

Regional Outlook

North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Nuclear Medicine Equipment Market?

The nuclear medicine equipment market consists of sales of gamma cameras, dose calibrators, radiation detectors and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.